Default
Allergy and immunology
Anaesthesia
Basic research
Cardiovascular medicine
Complementary medicine and alternative therapies
Critical care / intensive care
Dentistry / oral medicine
Dermatology
Emergency medicine
Endocrinology
Epidemiology
Ethics
Evidence-based medicine
Gastroenterology
Genetics
Geriatric medicine / aging
Haematology / blood transfusion
Health economics
Health policy
History of medicine
Infectious diseases
Internal medicine
Laboratory medicine
Legal and forensic medicine
Medical education
Medical informatics
Neurology
Nursing
Nutrition and metabolism
Obstetrics and gynaecology
Occupational and environmental medicine
Oncology
Ophthalmology
Organisation of health care
Otolaryngology / head and neck surgery
Paediatrics
Palliative care
Pathology
Patient-physician relationship
Pharmacology and therapeutics
Primary care, family medicine
Psychiatry and psychotherapy
Psychosomatics
Public health
Quality of care
Radiology
Rehabilitation medicine
Renal medicine
Respiratory medicine
Rheumatology
Sexual medicine
Sports medicine
Statistics and research methods
Surgery
Transplantation
Travel medicine
Urology
Response of a European surgical department to the COVID-19 crisis
At first sight, surgery appears to be only peripherally affected by the COVID.19 pandemic. However, the surgical department plays a key role in the response to this crisis. This article aims to provide a blueprint for a general surgery department’s response to this current pandemic crisis and also future events of similar magnitude.
COVID-19 and Iran: swimming with hands tied!
Like many other countries around the world, Iran is contending with the COVID-19 epidemic, but with the additional burden of international sanctions on supplies of medicines and medical equipment.
Diagnostic diversity – an indicator of institutional and regional healthcare quality
The diagnostic diversity index can be seen as an indicator of diagnostic precision - the higher the degree of diversity, the better the diagnostic precision.
Dual use in the 21st century: emerging risks and global governance
Dual use risks in the second decade of the 21st century are characterised by: diversification of dual use domains, digitalisation of potential threats, and the proliferation of actors.
A buyers’ club to improve access to hepatitis C treatment for vulnerable populations
High costs are an important barrier to treatment access for vulnerable and often uninsured patients with hepatitis C.
Predictors for shorter and longer length of hospital stay outliers: a retrospective case-control study of 8247 patients at a university hospital trauma department
Providing efficient healthcare is important for hospitals. Shorter and longer length of hospital stay (LOS) outliers influence financial results and reimbursement.
The inconsistent ethical oversight of healthcare quality data in Switzerland
Further consideration needs to be given to how regulations can be revised in a way that ensures that healthcare improvement activities using the same quality data in Switzerland are not either overregulated on one side or completely without control on the other.
Accidental or intentional exposure to potentially toxic medications, natural toxins and chemicals during pregnancy: analysis of data from Tox Info Suisse
Pregnant women are daily exposed to potentially harmful agents, such as food products and household chemicals, as well as medications. Affected women and health professionals are still often unsure about how to react.
Point prevalence of healthcare-associated infections and antibiotic use in three large Swiss acute-care hospitals
The current burden of healthcare-associated infections (HAIs) in Switzerland is unknown. Prevalence surveys have a long tradition in the field of infection prevention and control for measuring both HAI and antimicrobial use.
The impact of clinical trial units on the value of clinical research in Switzerland
A decade ago, the Swiss National Science Foundation instigated clinical trial units (CTUs) at the five university hospitals and St Gallen cantonal hospital, with the aim of improving the quality of Swiss academic clinical research projects.
